Capstone Holding Corp. (CAPS)
CAPS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.1242
-6.83% on the day
Market cap
$3.3M
Nano cap
Revenue · 2024
$44.9M
-7.2% on 2023
Net income · 2024
-$2.6M
-5.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2024.
Profile
| Field | Value |
|---|---|
| Ticker | CAPS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000887151 |
| SEC industry code | Wholesale-Lumber & Other Construction Materials |
| Incorporated in | DE |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $44.9M |
| Net income | -$2.6M |
| Operating income | -$638K |
| Net margin | -5.7% |
| Operating margin | -1.4% |
| Revenue growth | -7.2% |
| Cash | $11K |
| Total assets | $47.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM S-1 | S-1 | 2026-06-29 |
| Latest annual report AMENDMENT NO. 1 TO FORM 10-K | 10-K/A | 2026-04-17 |
| Latest quarterly / interim FORM 10-Q/A | 10-Q/A | 2026-08-12 |
| Latest current report FORM 8-K | 8-K | 2026-10-13 |
| Latest proxy FORM DEFA14A | DEFA14A | 2026-05-08 |
Source: SEC EDGAR submissions feed, 846 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| EOCN | Eocene Ltd. | $3.17 | -1.71% | $3.3M |
| GRI | GRI Bio Inc. | $1.55 | -1.27% | $3.4M |
| SXTP | 60 Degrees Pharmaceuticals Inc. | $0.9000 | -1.70% | $3.2M |
| CMND | Clearmind Medicine Inc. Common Shares | $6.23 | -4.74% | $3.2M |
| RDHL | Redhill Biopharma Ltd. | $0.5150 | -3.45% | $3.1M |
| APVO | Aptevo Therapeutics Inc. | $1.73 | -5.79% | $3.1M |
| XRTX | XORTX Therapeutics Inc. Common Shares | $1.68 | -2.33% | $3.1M |
| CVKD | Cadrenal Therapeutics Inc. | $0.9970 | +14.28% | $3.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier